The company’s annual turnover increased from N18.41 billion in 2018 to N20.76 billion in 2019.
On Thursday, May 24th during its 47th Annual General Meeting, shareholders of GlaxoSmithKline Consumer Nigeria Plc approved the declared special dividend of ₦8.4 billion and an ordinary dividend...
